ReviewCells2022

Reducing PDK1/Akt Activity: An Effective Therapeutic Target in the Treatment of Alzheimer's Disease.

Shaobin Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.